Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Dtg-Art'

Dtg-Art published presentations and documents on DocSlides.

DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
Superior Efficacy of Dolutegravir (DTG) Plus
Superior Efficacy of Dolutegravir (DTG) Plus
by celsa-spraggs
2 Nucleoside Reverse Transcriptase Inhibitors (NR...
DTG-Based Regimens Are Active in INI-Naive Patients With a
DTG-Based Regimens Are Active in INI-Naive Patients With a
by trish-goza
Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
The SA National PMTCT Guidelines (2019)
The SA National PMTCT Guidelines (2019)
by cleminal
Outline. The ideal PMTCT pathway . Detail of new i...
What’s New in WHO Treatment Guidelines
What’s New in WHO Treatment Guidelines
by aaron
July 23 2018 . What We Know About Safety Signals ...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by faustina-dinatale
and 22. nd. International AIDS Conference . Sele...
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
by liane-varnes
July 24 2018 . Overview on Safety of HIV Treatmen...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by luanne-stotts
and 22. nd. International AIDS Conference . Sele...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
by ethlyn
Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...
Neuropsychiatric manifestations and
Neuropsychiatric manifestations and
by Mindbender
sleep disturbances in children and adolescents ran...
Country Experience in Monitoring New
Country Experience in Monitoring New
by fauna
ARVs: Focus on Toxicity Monitoring . and Surveill...
Meg Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Paediatric ARV Drug Optimization 3 Review Summary report &
Paediatric ARV Drug Optimization 3 Review Summary report &
by neoiate
*\n\b...
Heather Watts MD Director of HIV Prevention, Program Quality Team
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
by liane-varnes
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...
Potential safety issue affecting women living with HIV using
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
JM Llibre , 1 C-C Hung,
JM Llibre , 1 C-C Hung,
by mohammad106
2. C Brinson,. 3. F Castelli,. 4. P-M Girard,. ...
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
Custom Hoodies - No Minimum, Custom DTG Atlanta at 3V Printing Store
by 3vprintingstore
In the bustling city of Atlanta, fashion-forward i...
Antiretrovirals for prevention in women of childbearing age:
Antiretrovirals for prevention in women of childbearing age:
by tremblay
issues to consider. Landon Myer. We all have “is...
Basic HIV Course for Health Professionals
Basic HIV Course for Health Professionals
by megan
Session 12: Contraceptives and HIV. Learning Objec...
Emergence of resistance in
Emergence of resistance in
by emma
HIV-1 Integrase . following dolutegravir (DTG) tre...
The Fast and The Continuous:
The Fast and The Continuous:
by bery
Dolutegravir-based Antiretroviral Therapy Achieves...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Clinical considerations for the
Clinical considerations for the
by helene
introduction . of . DTG. Nandita Sugandhi. ICAP at...